Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.05%

Cubist Pharmaceuticals Inc. (CBST)

-NasdaqGS
61.55 Jul 29, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 1,054,442   926,359   753,972  
Cost of Revenue260,310  230,057  172,864  
Gross Profit 794,132   696,302   581,108  
Operating Expenses
Research Development477,740  277,729  184,533  
Selling General and Administrative210,363  142,767  254,765  
Non Recurring79,619  38,700  9,279  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 26,410   237,106   132,531  
Income from Continuing Operations
Total Other Income/Expenses Net(32,452)(4,519)3,673  
Earnings Before Interest And Taxes(6,042)232,587  136,204  
Interest Expense37,602  32,991  31,415  
Income Before Tax(43,644)199,596  104,789  
Income Tax Expense(25,073)45,521  71,766  
Minority Interest -   -   -  
Net Income From Continuing Ops(18,571)154,075  33,023  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (18,571) 154,075   33,023  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (18,571) 154,075   33,023  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.